Product logins

Find logins to all Clarivate products below.


Interventional Oncology Devices | Asia Pacific | 2015 | Market Analysis

The Asia Pacific interventional oncology device market is one of the largest and fastest growing spaces in interventional medicine. Despite pricing pressures and high competition negatively impacting revenues, a large and fast growing patient base will lead to sizable growth in market value over the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional oncology devices in the Asia Pacific region across a 10-year period.

Related Medtech Insights Reports

Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging…
Report
Interventional Oncology Devices – Market Insights – Asia Pacific
The Asia Pacific interventional oncology device market will see strong growth through 2034, driven by updated clinical guidelines, broader access to minimally invasive cancer treatments, and…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Asia Pacific
The Asia Pacific EP mapping and ablation device market will experience strong growth through 2034, driven by rising procedure volumes, new product launches, increasing prevalence of cardiac…
Report
Aesthetic Injectables – Market Insights – Asia Pacific
The Asia Pacific aesthetic injectable market will continue to expand through 2034, fueled by continuous innovation and the introduction of differentiated products by leading global and regional…
Report
Sports Medicine Devices – Market Insights – Asia Pacific
Technological investments, adoption of premium-priced products, increased market awareness through educational programs, and improved surgeon training will drive rapid growth in the Asia Pacific…